Bangalore-based biotechnology company, Cambrian Bioworks has secured $1.45 million in seed funding. The company builds cutting-edge solutions for the rapidly expanding next-generation sequencing (NGS) and molecular diagnostic markets. The round was spearheaded by the Irani family office, which has invested in several private ventures across